Apotex a ‘standout’ stock since IPO despite Trump tariff threat, analysts say
- Posted on August 4, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
In brief
Generating AI summary…
Apotex a ‘standout’ stock since IPO despite Trump tariff threat, analysts say
Drug maker rebounded last week, trading 30 per cent higher than at its debut
